<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045411"><TermName>penclomedine</TermName><TermPronunciation>(pen-KLOH-meh-deen)</TermPronunciation><TermDefinition><DefinitionText>A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called alkylating agents.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000730951" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;penclomedine&quot;" language="en" id="_3"/><MediaLink ref="CDR0000730950" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;penclomedine&quot;" language="es" id="_4"/><SpanishTermName>penclomedine</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento del c√°ncer. Pertenece al tipo de medicamentos llamados alquilantes.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2005-02-11</DateLastModified></GlossaryTerm>
